The state of health in Indonesia's provinces, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
N Mboi, R Syailendrawati, SM Ostroff… - The Lancet Global …, 2022 - thelancet.com
Background Analysing trends and levels of the burden of disease at the national level can
mask inequalities in health-related progress in lower administrative units such as provinces …
mask inequalities in health-related progress in lower administrative units such as provinces …
Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment
JA Seddon, S Johnson, M Palmer… - Expert Review of …, 2021 - Taylor & Francis
Introduction An estimated 30,000 children develop multidrug-resistant (MDR) tuberculosis
(TB) each year, with only a small proportion diagnosed and treated. This field has historically …
(TB) each year, with only a small proportion diagnosed and treated. This field has historically …
Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis
Multidrug-resistant tuberculosis (MDR-TB) is a major health threat worldwide, causing a
significant economic burden to patients and their families. Due to the longer duration of …
significant economic burden to patients and their families. Due to the longer duration of …
Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient's perspective
Background Previously treated tuberculosis (TB) patients are a widely reported risk factor for
multidrug-resistant tuberculosis. Identifying patients' problems during treatment is necessary …
multidrug-resistant tuberculosis. Identifying patients' problems during treatment is necessary …
Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis
A Portnoy, T Yamanaka, P Nguhiu… - The Lancet Global …, 2023 - thelancet.com
Background People accessing and completing treatment for tuberculosis can face large
economic costs, even when treatment is provided free of charge. The WHO End TB Strategy …
economic costs, even when treatment is provided free of charge. The WHO End TB Strategy …
[PDF][PDF] Tuberculosis patient cost surveys: a handbook
World Health Organization - 2017 - apps.who.int
Tuberculosis (TB) is mainly a disease of poor and marginalized people and communities. An
already precarious socioeconomic situation can worsen considerably when an individual or …
already precarious socioeconomic situation can worsen considerably when an individual or …
[HTML][HTML] The cost and cost-effectiveness of novel tuberculosis vaccines in low-and middle-income countries: A modeling study
Background Tuberculosis (TB) is preventable and curable but eliminating it has proven
challenging. Safe and effective TB vaccines that can rapidly reduce disease burden are …
challenging. Safe and effective TB vaccines that can rapidly reduce disease burden are …
Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage
Background: As well as imposing an economic burden on affected households, the high
costs related to tuberculosis (TB) can create access and adherence barriers. This highlights …
costs related to tuberculosis (TB) can create access and adherence barriers. This highlights …
The economic burden of tuberculosis in Indonesia
D Collins, F Hafidz… - The International Journal of …, 2017 - ingentaconnect.com
SETTING: Indonesia has a high prevalence of tuberculosis (TB) and is one of the 22
countries with the highest TB burdens in the world. OBJECTIVE: To understand the …
countries with the highest TB burdens in the world. OBJECTIVE: To understand the …
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
U Khan, H Huerga, AJ Khan, CD Mitnick… - BMC infectious …, 2019 - Springer
Background At a time when programs were struggling to design effective regimens for the
treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing authorization of …
treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing authorization of …